Clinical progress note: Anti‐amyloid monoclonal antibodies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical progress note: Anti‐amyloid monoclonal antibodies

Published:2024-06-18 Issue: Volume: Page:
ISSN:1553-5592
Container-title:Journal of Hospital Medicine
language:en
Short-container-title:Journal of Hospital Medicine

Author:

Horstman Molly J.¹²^ORCID,Howell Shaun A.¹²,Martini Sharyl R.³

Affiliation:

1. Center for Innovations in Quality, Effectiveness and Safety Michael E. DeBakey VA Medical Center Houston Texas USA

2. Section of Health Services Research, Department of Medicine Baylor College of Medicine Houston Texas USA

3. National Neurology Program, Veterans Health Administration, Washington DC and Department of Neurology Baylor College of Medicine Houston Texas USA

Funder

Health Services Research and Development

Publisher

Wiley

Reference14 articles.

1. 2023 Alzheimer's disease facts and figures

2. Biogen Inc.Aduhelm (Aducanumab) [Package Insert]. US Food and Drug Administration.2022. Accessed November 7 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761178s005lbl.pdf

3. Eisai Inc.Leqembi (Lecanemab) [Package Insert]. US Food and Drug Administration. 2023. Accessed November 7 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761269Orig1s001lbl.pdf

4. Estimated Annual Spending on Lecanemab and Its Ancillary Costs in the US Medicare Program

5. Two randomized phase 3 studies of aducanumab in early Alzheimer's disease;Budd Haeberlein S;J Prev Alzheimers Dis,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP